MedTech

Photocure ASA appoints Dennis Camporeale as Chief Financial Officer, effective October 26, 2026, bringing 25 years of senior finance experience.

Leadership read: A change at the top rarely stays at the top. Photocure ASA's move reshapes the layer beneath it in MedTech as a new leader sets priorities and the team re-forms. Watch the first two or three appointments that follow; they signal direction more reliably than any statement.

curated · 2026-10-22 · context →

ProMedicus won a seven-year, $43m deal with US hospital group Virtua Health for its Visage 7 imaging software across five hospitals, with potential further revenue tied to usage.

Leadership read: Alliances broaden the commercial surface, and the leadership need follows. ProMedicus's partnership in MedTech widens demand for commercial and alliance leaders who turn an agreement into realised value. Across Americas, watch whether dedicated senior ownership is put on it; unowned alliances quietly lapse.

curated · 2026-10-21 · context →

CMR Surgical and Stryker have formed a strategic alliance granting Stryker an exclusive US commercial agency for the Versius surgical robot portfolio, with CMR retaining commercialisation outside the US.

Leadership read: Alliances broaden the commercial surface, and the leadership need follows. CMR Surgical's partnership in MedTech widens demand for commercial and alliance leaders who turn an agreement into realised value. Across Americas, watch whether dedicated senior ownership is put on it; unowned alliances quietly lapse.

curated · 2026-10-13 · context →

Stryker is investing $400m in UK-headquartered CMR Surgical and has secured a future buyout option, giving Stryker a route into the soft tissue robotic surgery market.

Leadership read: Fresh capital is a hiring signal before it is anything else. For CMR Surgical, a raise in MedTech funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where CMR Surgical hires first across EMEA; that is where the capital is really pointed.

curated · 2026-10-12 · context →

Boston Scientific appoints Joseph M. Fitzgerald as Executive Vice President and Chief Operating Officer, supported by new operating structure designed to increase efficiency and support continued growth.

Leadership read: A change at the top rarely stays at the top. Boston Scientific Corporation's move reshapes the layer beneath it in MedTech as a new leader sets priorities and the team re-forms. Watch the first two or three appointments that follow; they signal direction more reliably than any statement.

curated · 2026-10-07 · context →

Edwards Lifesciences received FDA approval for Autus, an expandable pulmonary valve designed for pediatric patients. This is the first FDA-approved heart valve designed to expand post-surgery to accommodate a child's growth.

Leadership read: A product move like this reshapes Edwards Lifesciences's org chart as much as its roadmap. Scaling in MedTech rests on product leadership that can carry a launch to adoption and commercial hires who turn early traction into pipeline. The Americas tell is whether senior GTM appointments follow; unsupported launches stall.

curated · 2026-10-02 · context →

Owens & Minor appointed Carrie Childress as its first Chief Marketing Officer in company history. Childress brings nearly 20 years of healthcare marketing, product management, and brand development experience.

Leadership read: A change at the top rarely stays at the top. Owens & Minor's move reshapes the layer beneath it in MedTech as a new leader sets priorities and the team re-forms. Watch the first two or three appointments that follow; they signal direction more reliably than any statement.

curated · 2026-10-01 · context →

PearlMatrix P-15 Peptide Enhanced Bone Graft received Medicare New Technology Add-on Payment (NTAP), enabling hospitals to claim additional reimbursement for lumbar fusion procedures using the product.

Leadership read: A product move like this reshapes Cerapedics Inc.'s org chart as much as its roadmap. Scaling in MedTech rests on product leadership that can carry a launch to adoption and commercial hires who turn early traction into pipeline. The Americas tell is whether senior GTM appointments follow; unsupported launches stall.

curated · 2026-10-01 · context →

Intuitive Surgical received CE mark approval for da Vinci SP system in transvaginal gynecologic procedures, a first-of-its-kind indication expanding the robot's minimally invasive surgery footprint in Europe.

Leadership read: Intuitive Surgical's launch shifts talent demand before revenue catches up. In MedTech, taking a release to scale rewards product leaders with a commercial edge and operators who build the post-launch motion. Watch whether Intuitive Surgical backs it with senior go-to-market hires across EMEA. That separates a platform move from a one-off.

curated · 2026-09-28 · context →

ProMedicus appointed Tim Reed, former MYOB CEO with 30+ years in technology leadership, as non-executive director effective October 1. This signals board-level strengthening in governance and strategic technology oversight.

Leadership read: A deliberate hiring build-out is a statement of intent about ProMedicus's next phase in MedTech. It points to deepening executive bench strength over the coming quarters, clustered around the capabilities being bet on. Across Oceania, the seniority and function of the hires map where the company thinks it is headed.

curated · 2026-09-23 · context →

Wearable Devices received a China patent allowance for pressure-based gesture control technology applicable to consumer electronics, XR devices, robotics, and physical AI applications.

Leadership read: Wearable Devices's launch shifts talent demand before revenue catches up. In MedTech, taking a release to scale rewards product leaders with a commercial edge and operators who build the post-launch motion. Watch whether Wearable Devices backs it with senior go-to-market hires across Asia. That separates a platform move from a one-off.

curated · 2026-09-23 · context →

Boston Scientific's spinal cord stimulation (SCS) leads linked to 1,081 serious injuries; FDA alert issued. Company facing personal injury lawsuits over SCS system malfunctions across medtech sector.

Leadership read: A breach is a governance event before it is a technical one. For Boston Scientific in MedTech, the hiring consequence is rarely more engineers; it is senior accountability: security, risk and data governance reporting high enough to change decisions. Across Americas, watch whether the response is a hire or a contractor; that distinction says how the board has read it.

curated · 2026-09-04 · context →